Optimization of Clotrimazole Emulgel: Evaluating the Effects of Oil Type, Oil Concentration, and Gellant Type on Physico-Chemical Performance Optimization of Clotrimazole Emulgel Formulation
Iranian Journal of Pharmaceutical Sciences,
Vol. 21 No. 1 (2025),
21 January 2025
,
Page 282-291
https://doi.org/10.22037/ijps.v21i1.47314
Abstract
Fungal infections of the skin are prevalent worldwide, and effective treatment requires innovative drug delivery systems. Emulgel, a novel formulation, offers several advantages, including non-greasiness, stain-free properties, improved patient compliance (particularly for individuals with hairy skin), enhanced spreadability, increased stability, and controlled drug release. This study investigates using emulgel as a delivery system for hydrophobic drugs, specifically Clotrimazole, in a hydrophilic base. Nine emulgel formulations were evaluated, focusing on three key factors: polymer type (Carbomer 940, Hydroxypropyl Methylcellulose K4M (HPMC K4M)), or a combination of both), and the type and percentage of the oily phase (5% Paraffin, 5% Isopropyl Myristate, and 7.5% Isopropyl Myristate). Three formulations failed to meet the mechanical stability criteria, while six formulations demonstrated stability across all tests. Drug release rates were as follows: F1 (81.43%), F2 (76.87%), F3 (85.56%), F7 (91.56%), F8 (87.89%), and F9 (97.64%). Over six hours, a commercially available Clotrimazole cream (Pars Daroo Company) released 71.11% of its drug content. Formulation 9 is the most effective formula, incorporating 5% Paraffin and a blend of Carbomer 940 and HPMC, and it followed the zero-order kinetic model. The inclusion of Paraffin, compared to Isopropyl Myristate, enhanced drug release due to the lower solubility of Clotrimazole in Paraffin. The Carbomer 940 and HPMC combination also provided optimal viscosity, ensuring stability, ease of application, and controlled release. It has also been shown that increasing oil concentration increases the drug's loading capacity while its release decreases.
- Emulgel
- clotrimazole
- Isopropyl Myristate
- Paraffin
- Carbomer 940
- HPMC
How to Cite
References
Akhtar, N., A. Verma, and K. Pathak, Topical delivery of drugs for the effective treatment of fungal infections of skin. Current pharmaceutical design, 2015. 21(20): p. 2892-2913.
Paolicellia, P., et al., The system SLN-Dextran hydrogel: An application for the topical delivery of ketoconazole. J Chem Pharm Res, 2011. 3(4): p. 410-21.
Rupvate, S.R., et al., Solid self‑emulsifying pellets: Solubility enhancement for oral delivery of poorly soluble BCS Class II drug. Journal of Drug Delivery and Therapeutics, 2022. 12(4-S): p. 171-176.
Khalil, Y.I., A.H. Khasraghi, and E.J. Mohammed, Preparation and evaluation of physical and, rheological properties of clotrimazole emulgel. Iraqi Journal of Pharmaceutical Sciences (P-ISSN: 1683-3597, E-ISSN: 2521-3512), 2011. 20(2): p. 19-27.
Singh Malik, D., N. Mital, and G. Kaur, Topical drug delivery systems: a patent review. Expert opinion on therapeutic patents, 2016. 26(2): p. 213-228.
Torin Huzil, J., et al., Drug delivery through the skin: molecular simulations of barrier lipids to design more effective noninvasive dermal and transdermal delivery systems for small molecules, biologics, and cosmetics. Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, 2011. 3(5): p. 449-462.
Barnes, T.M., et al., Vehicles for drug delivery and cosmetic moisturizers: review and comparison. Pharmaceutics, 2021. 13(12): p. 2012.
Monteiro, A., et al., Understanding Your Creams: Principles of Dermatological Formulation. Clin Exp Dermatol Ther, 2022. 7: p. 190.
Hasan, S., et al., Emulgel: A review. Asian Journal of Pharmaceutical Research, 2021. 11(4): p. 263-268.
Alexander, A., et al., Recent expansions in an emergent novel drug delivery technology: Emulgel. Journal of Controlled Release, 2013. 171(2): p. 122-132.
Yadav, R., et al., Emulgel A Reliable System for Topical Delivery of Lipophilic Drugs in Present Scenario. Research Journal of Pharmacy and Technology, 2022. 15(6): p. 2845-2848.
Engelbrecht, T., et al., Study of the influence of the penetration enhancer isopropyl myristate on the nanostructure of stratum corneum lipid model membranes using neutron diffraction and deuterium labelling. Skin pharmacology and physiology, 2012. 25(4): p. 200-207.
Clarke’s Analysis of Drugs and Poisons 4th ed. ed, ed. A.C.a.O. Moffat, M.D. and Widdop, B. . 2011 Pharmaceutical Press
Quiñones, D. and E.S. Ghaly, Formulation and characterization of nystatin gel. Puerto Rico health sciences journal, 2008. 27(1).
Ogedengbe, O.T. and O.M. Kolawole, Formulation and evaluation of fluconazole emulgels for potential treatment of vaginal candidiasis. Heliyon, 2024. 10(6).
Hashem, F.M., et al., Formulation, characterization, and clinical evaluation of microemulsion containing clotrimazole for topical delivery. Aaps Pharmscitech, 2011. 12: p. 879-886.
Deveda, P., et al., Gellified emulsion for sustain delivery of itraconazole for topical fungal diseases. International Journal of Pharmacy and Pharmaceutical Sciences, 2010. 2(1): p. 104-112.
Mohamed, M.I., Optimization of chlorphenesin emulgel formulation. The AAPS journal, 2004. 6: p. 81-87.
Đoković, J.B., et al., The impact of the oil phase selection on physicochemical properties, long-term stability, in vitro performance and injectability of curcumin-loaded PEGylated nanoemulsions. Pharmaceutics, 2022. 14(8): p. 1666.
- Abstract Viewed: 519 times
- IJPS_Volume21_Issue1_Pages282-291 Downloaded: 262 times